Hau CS et al. |
Suppressive effects of antimycotics on thymic stromal lymphopoietin production in human keratinocytes. |
2013 |
J. Dermatol. Sci. |
pmid:23688403
|
Fukuchi K et al. |
Apoptosis in human oral squamous cell carcinomas is induced by 15-deoxy-delta 12,14-prostaglandin J2 but not by troglitazone. |
2003 |
J. Dent. Res. |
pmid:14514760
|
Lutzow YS et al. |
15-Deoxy-Delta12,14-prostaglandin J2 induces chemokine expression, oxidative stress and microfilament reorganization in bovine mammary epithelial cells. |
2008 |
J. Dairy Res. |
pmid:18226310
|
Kawahito Y et al. |
15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats. |
2000 |
J. Clin. Invest. |
pmid:10903334
|
Adams M et al. |
Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation. |
1997 |
J. Clin. Invest. |
pmid:9399962
|
Powell WS |
15-Deoxy-delta12,14-PGJ2: endogenous PPARgamma ligand or minor eicosanoid degradation product? |
2003 |
J. Clin. Invest. |
pmid:12975467
|
Bell-Parikh LC et al. |
Biosynthesis of 15-deoxy-delta12,14-PGJ2 and the ligation of PPARgamma. |
2003 |
J. Clin. Invest. |
pmid:12975479
|
Su CG et al. |
A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response. |
1999 |
J. Clin. Invest. |
pmid:10449430
|
Chearwae W and Bright JJ |
15-deoxy-Delta(12,14)-prostaglandin J(2) and curcumin modulate the expression of toll-like receptors 4 and 9 in autoimmune T lymphocyte. |
2008 |
J. Clin. Immunol. |
pmid:18463970
|
Kasim-Karakas SE et al. |
Metabolic and endocrine effects of a polyunsaturated fatty acid-rich diet in polycystic ovary syndrome. |
2004 |
J. Clin. Endocrinol. Metab. |
pmid:14764771
|
Lappas M et al. |
Regulation of proinflammatory cytokines in human gestational tissues by peroxisome proliferator-activated receptor-gamma: effect of 15-deoxy-Delta(12,14)-PGJ(2) and troglitazone. |
2002 |
J. Clin. Endocrinol. Metab. |
pmid:12364456
|
Lindström TM and Bennett PR |
15-Deoxy-{delta}12,14-prostaglandin j2 inhibits interleukin-1{beta}-induced nuclear factor-{kappa}b in human amnion and myometrial cells: mechanisms and implications. |
2005 |
J. Clin. Endocrinol. Metab. |
pmid:15755849
|
Zhao X et al. |
15d-Prostaglandin J2 activates peroxisome proliferator-activated receptor-gamma, promotes expression of catalase, and reduces inflammation, behavioral dysfunction, and neuronal loss after intracerebral hemorrhage in rats. |
2006 |
J. Cereb. Blood Flow Metab. |
pmid:16208315
|
Pereira MP et al. |
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2 cause potent neuroprotection after experimental stroke through noncompletely overlapping mechanisms. |
2006 |
J. Cereb. Blood Flow Metab. |
pmid:16034372
|
Pignatelli M et al. |
The peroxisome proliferator-activated receptor gamma is an inhibitor of ErbBs activity in human breast cancer cells. |
2001 |
J. Cell. Sci. |
pmid:11739643
|
Tonge D et al. |
Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins. |
2008 |
J. Cell. Sci. |
pmid:18650498
|
Lin TH et al. |
15-deoxy-Δ(12,14) -prostaglandin-J2 and ciglitazone inhibit TNF-α-induced matrix metalloproteinase 13 production via the antagonism of NF-κB activation in human synovial fibroblasts. |
2011 |
J. Cell. Physiol. |
pmid:21344384
|
Ulivi V et al. |
15-deoxy-delta 12,14-prostaglandin J(2) inhibits the synthesis of the acute phase protein SIP24 in cartilage: Involvement of COX-2 in resolution of inflammation. |
2008 |
J. Cell. Physiol. |
pmid:18615580
|
Castaño E and Gil J |
15-deoxy-delta12,14 prostaglandin J2 synergizes with phorbol ester to induce proliferation in Swiss 3T3 cells independently of peroxisome proliferator-activated receptor gamma and PGD2 receptors. |
2003 |
J. Cell. Physiol. |
pmid:12704651
|
Baek K et al. |
Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow. |
2012 |
J. Cell. Physiol. |
pmid:22307523
|
Qin HD et al. |
Upregulation of peroxisome proliferator-activated receptor-gamma and NADPH oxidases are involved in restenosis after balloon injury. |
2009 |
J. Cell. Physiol. |
pmid:19562688
|
Lin TH et al. |
Upregulation of heme oxygenase-1 inhibits the maturation and mineralization of osteoblasts. |
2010 |
J. Cell. Physiol. |
pmid:20020468
|
Zhou J et al. |
Bone-marrow-derived mesenchymal stem cells inhibit gastric aspiration lung injury and inflammation in rats. |
2016 |
J. Cell. Mol. Med. |
pmid:27061967
|
Toaldo C et al. |
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network in colon cancer cells. |
2010 |
J. Cell. Mol. Med. |
pmid:19912441
|
Glorian M et al. |
Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes. |
1998 |
J. Cell. Biochem. |
pmid:9518257
|
Chen Y et al. |
Effects of PPARgamma agonists on cell survival and focal adhesions in a Chinese thyroid carcinoma cell line. |
2006 |
J. Cell. Biochem. |
pmid:16795079
|
Li N et al. |
Molecular mechanisms underlying the inhibition of IFN-γ-induced, STAT1-mediated gene transcription in human macrophages by simvastatin and agonists of PPARs and LXRs. |
2011 |
J. Cell. Biochem. |
pmid:21268089
|
Goetze S et al. |
Troglitazone inhibits mitogenic signaling by insulin in vascular smooth muscle cells. |
2000 |
J. Cardiovasc. Pharmacol. |
pmid:10813377
|
Yuan Z et al. |
Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells. |
2004 |
J. Cardiovasc. Pharmacol. |
pmid:15167281
|
Goetze S et al. |
PPAR gamma-ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells. |
1999 |
J. Cardiovasc. Pharmacol. |
pmid:10226869
|
Bräutigam K et al. |
Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines. |
2011 |
J. Cancer Res. Clin. Oncol. |
pmid:20878528
|
Lehmann JM et al. |
Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. |
1997 |
J. Biol. Chem. |
pmid:9013583
|
Subbaramaiah K et al. |
Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein/p300. |
2001 |
J. Biol. Chem. |
pmid:11278336
|
Nelson SM et al. |
Selenoprotein Expression in Macrophages Is Critical for Optimal Clearance of Parasitic Helminth Nippostrongylus brasiliensis. |
2016 |
J. Biol. Chem. |
pmid:26644468
|
Shibata T et al. |
15-deoxy-delta 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. |
2002 |
J. Biol. Chem. |
pmid:11786541
|
Inoue H et al. |
Feedback control of cyclooxygenase-2 expression through PPARgamma. |
2000 |
J. Biol. Chem. |
pmid:10827178
|
Jiang JG et al. |
Peroxisome proliferator-activated receptor gamma-mediated transcriptional up-regulation of the hepatocyte growth factor gene promoter via a novel composite cis-acting element. |
2001 |
J. Biol. Chem. |
pmid:11292834
|
Cheng S et al. |
Activation of peroxisome proliferator-activated receptor gamma inhibits interleukin-1beta-induced membrane-associated prostaglandin E2 synthase-1 expression in human synovial fibroblasts by interfering with Egr-1. |
2004 |
J. Biol. Chem. |
pmid:15023995
|
Alvarez-Maqueda M et al. |
15-deoxy-delta 12,14-prostaglandin J2 induces heme oxygenase-1 gene expression in a reactive oxygen species-dependent manner in human lymphocytes. |
2004 |
J. Biol. Chem. |
pmid:15024026
|
Relic B et al. |
15-deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. |
2004 |
J. Biol. Chem. |
pmid:15004016
|
Nie M et al. |
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists. |
2005 |
J. Biol. Chem. |
pmid:15531761
|
Lennon AM et al. |
MAP kinase cascades are activated in astrocytes and preadipocytes by 15-deoxy-Delta(12-14)-prostaglandin J(2) and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor gamma-independent mechanisms involving reactive oxygenated species. |
2002 |
J. Biol. Chem. |
pmid:12052825
|
Ho TC et al. |
15-deoxy-Delta(12,14)-prostaglandin J2 induces vascular endothelial cell apoptosis through the sequential activation of MAPKS and p53. |
2008 |
J. Biol. Chem. |
pmid:18718914
|
Caivano M et al. |
15-Deoxy-Delta12,14-prostaglandin J2 regulates endogenous Cot MAPK kinase kinase 1 activity induced by lipopolysaccharide. |
2003 |
J. Biol. Chem. |
pmid:14557273
|
Xin X et al. |
Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo. |
1999 |
J. Biol. Chem. |
pmid:10085162
|
Pérez-Sala D et al. |
Molecular basis for the direct inhibition of AP-1 DNA binding by 15-deoxy-Delta 12,14-prostaglandin J2. |
2003 |
J. Biol. Chem. |
pmid:14532268
|
Worley JR et al. |
Metalloproteinase expression in PMA-stimulated THP-1 cells. Effects of peroxisome proliferator-activated receptor-gamma (PPAR gamma) agonists and 9-cis-retinoic acid. |
2003 |
J. Biol. Chem. |
pmid:14534304
|
Lim SY et al. |
15-Deoxy-Delta12,14-prostaglandin J(2) protects against nitrosative PC12 cell death through up-regulation of intracellular glutathione synthesis. |
2004 |
J. Biol. Chem. |
pmid:15319433
|
Shibata T et al. |
Thioredoxin as a molecular target of cyclopentenone prostaglandins. |
2003 |
J. Biol. Chem. |
pmid:12709421
|
Yu X et al. |
Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase. |
2006 |
J. Biol. Chem. |
pmid:16857669
|